期刊文献+

子痫前期孕妇孕早期血清miR-520g表达分析 被引量:6

The analysis of serum miR-520g expression in the early stage of preeclampsia among pregnant patients
下载PDF
导出
摘要 目的探讨血清微小RNA(miR)-520g在子痫前期(PE)患者孕期的变化及意义。方法分别提取30例PE患者和30名正常妊娠者早、中、晚孕期血清中的循环miR,利用实时荧光定量逆转录聚合酶链反应(PCR)检测血清中的miR-520g的表达量,比较两组间不同孕期miR-520g的差异。结果正常妊娠组随孕程进展血清miR-520g的表达量增加;与正常妊娠组相比,PE组孕早期miR-520g显著增加,PE组孕中、晚期的血清miR-520g表达量与正常妊娠组差异无统计学意义。结论孕早期血清miR-520g可能是PE预测的良好标志物。 Objective To investigate the change and significance of serum microRNA ( miR)-520g in preeclampsia among pregnant patients .Methods Serum cycling miR was extracted from 30 patients with preeclampsia and 30 healthy pregnant women at early , middle and late pregnant stages .The expression of miR-520g was determined by quantitive reverse transcription polymerase chain reaction ( PCR ) , and the difference between the 2 groups was analyzed statistically.Results MiR-520g increased with pregnant days in healthy pregnant group .MiR-520g in early pregnant stage of preeclampsia group increased comparing with that of healthy pregnant group , whereas no significant difference was observed in middle and late pregnant stages between preeclampsia group and healthy pregnant group .Conclusions Serum miR-520g in early pregnant stage may be a potential biomarker for the prediction of preeclampsia .
出处 《检验医学》 CAS 2015年第4期345-348,共4页 Laboratory Medicine
基金 上海市卫生局青年科研项目(20124Y080)
关键词 子痫前期 微小RNA 血清 生物标志物 Preeclampsia MicroRNA Serum Biomarker
  • 相关文献

参考文献12

  • 1YOUNG BC, LEVINE R J, KARUMANCHI SA. Pathogenesis of preeclampsia [ J ]. Annu Rev Pathol, 2010, 5 : 173-192.
  • 2LIANG Y, RIDZON D, WONG L, et al. Characterization of microRNA expression profiles in normal human tissues [ J]. BMC Genomics, 2007, 8 : 166.
  • 3乐杰.妇产科学[M].7版.北京:人民卫生出版社,2009:92-99.
  • 4BARTEL DP. MicroRNAs: genomics, biogenesis, mechanism, and function [ J]. Cell, 2004, 116 (2) : 281-297.
  • 5MITCHELL PS, PARKIN RK, KROH EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection [ J]. Proc Natl Acad Sci USA, 2008, 105(30) :10513-10518.
  • 6袁小松,张一鸣,蒋雅琴,蒋丽霞.血清可溶性血管内皮生长因子受体1/胎盘生长因子比值作为预测子痫前期患病风险的价值[J].检验医学,2010,25(10):784-786. 被引量:8
  • 7PINELES BL, ROMERO R, MONTENEGRO D, et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients withpreeclampsia [J]. Am J Obstet Gynecol, 2007, 196 (3) :261. e1-261, e6.
  • 8ZHU XM, HAN T, SARGENT IL, et al. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies [J]. Am J Obstet Gynecol, 2009, 200(6) :661. e1- 661. e7.
  • 9ENQUOBAHRIE DA, ABETEW DF, SORENSEN TK, et al. Placental microRNA expression in pregnancies complicated by preeclampsia [ J]. Am J Obstet Gynecol, 2011,204(2) :178. e12-178, e21.
  • 10YANG Q, LU J, WANG S, et al. Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women [ J ]. Clin Chim Acta, 2011,412(23-24) :2167-2173.

二级参考文献8

  • 1乐杰主编.妇产科学[M].第7版.北京:人民卫生出版社,2009.271-272.
  • 2Sibai B,Dekker G,Kupferminc M.Pre-eclampsia[J].Lancet,2005,365(9461):785-799.
  • 3Levine RJ,Maynard SE,Qian C,et al.Circulating angiogenic factors and the risk of preeclampsia[J].N Engl J Med,2004,350(7):672-683.
  • 4Chaiworapongsa T,Romero R,Kim YM,et al.Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia[J].J Matern Fetal Neonatal Med,2005,17(1):3-18.
  • 5Romero R,Nien JK,Espinoza J,et al.A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate[J].J Matern Fetal Neonatal Med,2008,21(1):9-23.
  • 6Moore Simas TA,Crawford SL,Solitro MJ,et al.Angiogenic factors for the prediction of preeclampsia in high-risk women[J].Am J Obstet Gynecol,2007,197(3):244.e1-244.e8.
  • 7Koga K,Osuga Y,Yoshino O,et al.Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia[J].J Clin Endocrinol Metab,2003,88(5):2348-2351.
  • 8Chaiworapongsa T,Romero R,Espinoza J,et al.Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia[J].Am J Obstet Gynecol,2004,190(6):1541-1547.

共引文献241

同被引文献35

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部